Eli Lilly and Co Newsroom

Express News | Alchemab Therapeutics: Agreement With Lilly to License Atlx-1282

Reuters03:31 ET

Alchemab Therapeutics Signs Landmark $415m Licensing Agreement for ATLX-1282 With Eli Lilly and Company

PR Newswire03:30 ET

'Trump To Sign Order To Encourage Domestic Drug Manufacturing' - Washington Post

Benzinga23:04 ET

Citi maintains INNOVENT BIO's "Outperform the Industry" rating and raises the Target Price to 66 Hong Kong dollars.

CITIC published a Research Report stating that it maintains INNOVENT BIO (01801) Net income forecasts for 2025/2026 at 0.472 billion yuan/1.298 billion yuan unchanged. The firm maintains an outperform rating in the Industry. Considering the maturity of the next-generation flagship product IBI363 PoC data and the progress of the ADC pipeline, it is expected to unlock a broader Global commercialization space. Based on the DCF model, the firm raised the Target Price by 12.2% to 66 Hong Kong dollars, which has an upside potential of 20.2% compared to the current stock price. Event: On May 1, the company announced that product revenue for the first quarter of 2025 exceeded 2.4 billion yuan, maintaining over 40% year-on-year growth.

Sina Hong Kong Stocks22:37 ET

Eli Lilly and Co To Go Ex-Dividend On May 16th, 2025 With 1.5 USD Dividend Per Share

Moomoo News19:35 ET

Leerink Partners Maintains Eli Lilly and Co(LLY.US) With Buy Rating, Maintains Target Price $944

Moomoo News19:31 ET · Ratings

Fund Update: National Mutual Insurance Federation of Agricultural Cooperatives Added 15,200 Shares of ELI LILLY ($LLY) to Their Portfolio

Quiver Quantitative14:16 ET

Express News | Eli Lilly and Co - Declares Q2 2025 Dividend of $1.50 per Share

Reuters12:47 ET

Eli Lilly and Company Just Missed EPS By 26%: Here's What Analysts Think Will Happen Next

Simply Wall StMay 5 09:02 ET

Scribe Therapeutics to Highlight In Vivo CRISPR-based Genome Editing Data for Duchenne Muscular Dystrophy at ASGCT 2025, in Addition to Joint Presentation With Prevail Therapeutics, a Part of Lilly's Gene Therapy Division

Business WireMay 5 09:00 ET

Lilly Declares Second-quarter 2025 Dividend

Eli Lilly & Co.May 5 00:00 ET

UBS Group has lowered the Target Price for Eli Lilly and Co to $1,050.

UBS Group: Downgraded Eli Lilly and Co's Target Price from $1100 to $1050, maintaining a "Buy" rating.

Gelonghui FinanceMay 4 11:48 ET

UnitedHealth's Stock Is Ailing. A Bigger Business Hasn't Helped. -- Barrons.com

Barron'sMay 4 00:05 ET

Healthcare Sector Flexes Earnings Muscle, but Top-line Cracks Show

Seeking AlphaMay 3 18:10 ET

Eli Lilly's Stock Selloff Is Overdone, Analysts Say. Here's Why.

Barron'sMay 3 03:18 ET

Overview of international financial hot topics from last night to this morning_ May 3, 2025_ Financial news.

To view more global financial News, please move to the 7×24 hour real-time financial news market close: the S&P index has set a record for the longest consecutive rise in 20 years, with market attention on data and trade negotiation prospects. On May 2, the top 20 trading volumes of US stocks: Apple fell 3.7%, and the Earnings Reports highlight tariff and growth concerns. On Friday, China Concept Stocks rose broadly, with Taiwan Semiconductor up 3.81% and Alibaba up 4.35%. This week, Brent crude oil plummeted 8.3%, and Crude Oil fell 7.5%. Spot Gold fell 2.4% this week, and the Philadelphia Gold and Silver Index cumulatively declined over 3.5%. European stocks rose for nine consecutive days, nearing recovery of losses since the announcement of US tariffs.

Global market report.May 2 18:32 ET

Overnight news: U.S. stocks closed higher, Trump announced the 2026 budget plan, Bezos plans to sell $4.8 billion worth of Amazon stocks, Barclays and Goldman Sachs expect the Federal Reserve to lower interest rates in July.

To view more global financial News, please move to the 7×24 hour real-time financial news market close: the S&P index has set a record for the longest consecutive rise in 20 years, with market attention on data and trade negotiation prospects. On May 2, the top 20 trading volumes of US stocks: Apple fell 3.7%, and the Earnings Reports highlight tariff and growth concerns. On Friday, China Concept Stocks rose broadly, with Taiwan Semiconductor up 3.81% and Alibaba up 4.35%. This week, Brent crude oil plummeted 8.3%, and Crude Oil fell 7.5%. Spot Gold fell 2.4% this week, and the Philadelphia Gold and Silver Index cumulatively declined over 3.5%. European stocks rose for nine consecutive days, nearing recovery of losses since the announcement of US tariffs.

Global market report.May 2 18:30 ET

Express News | UBS Maintains Buy on Eli Lilly, Lowers Price Target to $1050

BenzingaMay 2 18:23 ET

Eli Lilly Analyst Ratings

BenzingaMay 2 18:23 ET · Ratings

Eli Lilly and Co Options Spot-On: On May 2nd, 90,297 Contracts Were Traded, With 329.36K Open Interest

Moomoo NewsMay 2 16:30 ET